Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Squamous Cell

Explore clinical trials studying Neoplasms, Squamous Cell. Study availability and eligibility vary by location and protocol.

815 public trials 208 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Squamous Cell trial results

Active, Not Recruiting

Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in Combination

NCT04868877

Conditions
Carcinoma, Carcinoma, Squamous Cell, Colonic Diseases, +24 more
Locations
  • University of California, Irvine Orange, California, United States
  • Sarah Cannon Research Institute Nashville, Tennessee, United States
  • START Mountain Region West Valley City, Utah, United States
  • Next Oncology Virginia Fairfax, Virginia, United States
View all 51 locations
View Trial Details
Active, Not Recruiting

A Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) (Pembrolizumab Formulated With Berahyaluronidase Alfa (MK-5180)) in Japanese Participants With Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma (R/M cSCC) or Locally Advanced (LA) Unresectable cSCC (MK-3475A-E39)

NCT06041802

Conditions
Carcinoma, Carcinoma, Squamous Cell, Neoplasms, +5 more
Locations
  • Nagoya University Hospital ( Site 0003) Nagoya, Aichi-ken, Japan
  • Sapporo Medical University Hospital ( Site 0002) Sapporo, Hokkaido, Japan
  • Yokohama City University Hospital ( Site 0016) Yokohama, Kanagawa, Japan
  • Tohoku University Hospital ( Site 0019) Sendai, Miyagi, Japan
View all 18 locations
View Trial Details
Active, Not Recruiting

Analyzing Clinical Outcomes and Genomic Data of American Indian Patient Population

NCT05863052

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +46 more
Locations
  • Arizona Cancer Center at the Unvieristy of Arizona Tucson, Arizona, United States
  • University of New Mexico Comprehensive Cancer Center Albuquerque, New Mexico, United States
  • Stephenson Cancer Center Oklahoma City, Oklahoma, United States
  • Monument Health Cancer Care Institute Rapid City, South Dakota, United States
View Trial Details
Active, Not Recruiting

Pembrolizumab Plus Olaparib in LA-HNSCC

NCT05366166

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Indiana University Simon Comprehensive Cancer Center Indianapolis, Indiana, United States
  • University of Louisville, Brown Cancer Center Louisville, Kentucky, United States
  • UNC Lineberger Chapel Hill, North Carolina, United States
  • Medical University of South Carolina (MUSC) Charleston, South Carolina, United States
View Trial Details

Related conditions